Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
LyondellBasell Industries
LYB
$19.2B
| $388M | 0.02% |
8,971,741
+1,300,271
| +17% | +$58.9M |
|
627
Lumentum
LITE
$69.3B
| $388M | 0.02% |
1,051,759
+105,410
| +11% | +$27.1M |
|
628
Lennar Class A
LEN
$21.2B
| $387M | 0.02% |
3,762,980
-586,717
| -13% | -$70.9M |
|
629
Alnylam Pharmaceuticals
ALNY
$29.3B
| $386M | 0.02% |
970,157
+244,096
| +34% | +$108M |
|
630
Omnicom Group
OMC
$23.4B
| $385M | 0.02% |
4,770,074
-1,107,432
| -19% | -$84.6M |
|
631
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.84B
| $384M | 0.02% |
8,670,709
+778,170
| +10% | +$33.9M |
|
632
Nordson
NDSN
$17.3B
| $381M | 0.02% |
1,582,637
+92,970
| +6% | +$21.8M |
|
633
Keysight
KEYS
$58.3B
| $380M | 0.02% |
1,871,983
-135,855
| -7% | -$25.2M |
|
634
Labcorp
LH
$25.9B
| $378M | 0.02% |
1,505,539
-1,831
| -0.1% | -$486K |
|
635
Manhattan Associates
MANH
$11.4B
| $378M | 0.02% |
2,178,422
+53,037
| +2% | +$9.7M |
|
636
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $377M | 0.02% |
5,091,894
+93,936
| +2% | +$6.91M |
|
637
Scotiabank
BNS
$108B
| $377M | 0.02% |
5,110,450
+773,821
| +18% | +$52.6M |
|
638
Constellation Brands
STZ
$23.2B
| $376M | 0.02% |
2,725,174
-35,323
| -1% | -$4.85M |
|
639
Humana
HUM
$46.2B
| $375M | 0.02% |
1,465,669
-238,738
| -14% | -$62.6M |
|
640
First Trust Long/Short Equity ETF
FTLS
$2.49B
| $373M | 0.02% |
5,252,510
+78,397
| +2% | +$5.54M |
|
641
Estee Lauder
EL
$32B
| $373M | 0.02% |
3,560,620
-965,116
| -21% | -$93.7M |
|
642
Vanguard Russell 1000 ETF
VONE
$8.68B
| $371M | 0.02% |
1,201,654
+36,686
| +3% | +$11.2M |
|
643
Canadian Natural Resources
CNQ
$93.8B
| $371M | 0.02% |
10,946,534
-288,051
| -3% | -$9.34M |
|
644
Centene
CNC
$32.5B
| $370M | 0.02% |
9,002,570
+603,585
| +7% | +$22.6M |
|
645
Thomson Reuters
TRI
$44.1B
| $370M | 0.02% |
2,759,045
+655,464
| +31% | +$94.9M |
|
646
Manulife Financial
MFC
$73.5B
| $369M | 0.02% |
10,175,194
-71,466
| -0.7% | -$2.43M |
|
647
Toast
TOST
$19.9B
| $368M | 0.02% |
10,372,626
+653,487
| +7% | +$23.6M |
|
648
Brown & Brown
BRO
$23.9B
| $368M | 0.02% |
4,620,122
-74,467
| -2% | -$6.21M |
|
649
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $367M | 0.02% |
7,638,041
+118,161
| +2% | +$5.67M |
|
650
iShares Russell Top 200 Growth ETF
IWY
$16.6B
| $366M | 0.02% |
1,322,246
+15,710
| +1% | +$4.35M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.